Ashley McEvoy bought $1.0M of Insulet (PODD)
Executed Feb 20, disclosed Feb 23, 3 days later.
Over the 21 trading sessions from the disclosed entry session (Feb 23), the stock returned -7.6% (delay-adjusted); from the execution session (Feb 20), -7.6%. Derived: entry at the session's open, exit at the close 20 sessions later.
Ashley McEvoy (President and CEO) filed 2 Form 4 reports in the trailing twelve months (2 purchases, 0 sales), most often in Insulet Corporation (PODD). Across 1 priced purchase filing, the average 21-session return was -7.6% from execution and -7.6% from disclosure (delay-adjusted; derived). The largest single filing was $1.0M of PODD (4,300 sh × $239.35, as filed), executed Feb 20.
Healthcare · Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United Sta…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→1,100 sh × $147.47
Exec Aug 21
Filed Aug 24 · 7:08 AM ET